The TOR (target of rapamycin) proteins are found in all eukaryotes. TOR has a protein kinase domain, as well as other domains through which it interacts with partner proteins to form at least two types of multiprotein complex, TORC1 and TORC2 (TOR complexes 1 and 2). Rapamycin, an antibiotic and immunosuppressant, inhibits functions of TORC1. Use of this drug has revealed roles for TORC1 and its mammalian counterpart, mTORC1, in promoting many anabolic processes. mTORC1 signalling is activated by growth factors and nutrients. It is highly active in many cancers and plays a role in tumorigenesis and in other diseases. Much less is known so far about the functions and regulation of (m)TORC2. The goal of this meeting was to bring together researchers studying the roles of mTORC1/2 in normal cell and animal physiology in diverse systems, as well as scientists exploring the therapeutic value of inhibiting mTOR (mammalian TOR) signalling.
Skip Nav Destination
Article navigation
April 2011
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
March 22 2011
mTOR Signalling in Health and Disease
Christopher G. Proud
Christopher G. Proud
1
1School of Biological Sciences, Life Sciences Building, University of Southampton, Southampton SO17 1BJ, U.K.
1email C.G.Proud@soton.ac.uk
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 13 2011
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© The Authors Journal compilation © 2011 Biochemical Society
2011
Biochem Soc Trans (2011) 39 (2): 431–436.
Article history
Received:
January 13 2011
Citation
Christopher G. Proud; mTOR Signalling in Health and Disease. Biochem Soc Trans 1 April 2011; 39 (2): 431–436. doi: https://doi.org/10.1042/BST0390431
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.